PTC Therapeutics Expands Rare Disease Portfolio with 'Unique Opportunity' - PTC Therapeutics (NASDAQ:PTCT
Xenon Pharmaceuticals Rallies After Pivotal Data Shows Major Drop In Monthly Seizures - Xenon Pharmaceuticals (NASDAQ:XENE)